Published in Nature on June 13, 1991
An evaluation of genetic distances for use with microsatellite loci. Genetics (1995) 8.79
Genetic architecture of quantitative traits in mice, flies, and humans. Genome Res (2009) 4.62
A nonparametric approach for mapping quantitative trait loci. Genetics (1995) 4.49
Evidence that the T cell repertoire of normal rats contains cells with the potential to cause diabetes. Characterization of the CD4+ T cell subset that inhibits this autoimmune potential. J Exp Med (1993) 3.10
The Min (multiple intestinal neoplasia) mutation: its effect on gut epithelial cell differentiation and interaction with a modifier system. J Cell Biol (1992) 2.76
Establishment of NOD-Pdcd1-/- mice as an efficient animal model of type I diabetes. Proc Natl Acad Sci U S A (2005) 2.49
CD8 T cell clones from young nonobese diabetic (NOD) islets can transfer rapid onset of diabetes in NOD mice in the absence of CD4 cells. J Exp Med (1996) 2.42
Genetic analysis of MRL-lpr mice: relationship of the Fas apoptosis gene to disease manifestations and renal disease-modifying loci. J Exp Med (1992) 2.27
Forward and reverse genetic approaches to behavior in the mouse. Science (1994) 2.20
Nonobese diabetic (NOD) mice congenic for a targeted deletion of 12/15-lipoxygenase are protected from autoimmune diabetes. Diabetes (2007) 1.96
A likelihood approach to populations samples of microsatellite alleles. Genetics (1997) 1.79
Genetic analysis of type 1 diabetes using whole genome approaches. Proc Natl Acad Sci U S A (1995) 1.66
On genetic map functions. Genetics (1996) 1.64
Genetic mapping of a murine locus controlling development of T helper 1/T helper 2 type responses. Proc Natl Acad Sci U S A (1996) 1.59
Mouse models for the study of autoimmune type 1 diabetes: a NOD to similarities and differences to human disease. Semin Immunopathol (2010) 1.58
Failure to censor forbidden clones of CD4 T cells in autoimmune diabetes. J Exp Med (2002) 1.58
Reduced incidence and delayed onset of diabetes in perforin-deficient nonobese diabetic mice. J Exp Med (1997) 1.55
Use of recombinant congenic and congenic strains of NOD mice to identify a new insulin-dependent diabetes resistance gene. J Exp Med (1994) 1.53
One hundred years of mouse genetics: an intellectual history. II. The molecular revolution (1981-2002). Genetics (2003) 1.53
Insulitis in transgenic mice expressing tumor necrosis factor beta (lymphotoxin) in the pancreas. Proc Natl Acad Sci U S A (1992) 1.51
Resistance alleles at two non-major histocompatibility complex-linked insulin-dependent diabetes loci on chromosome 3, Idd3 and Idd10, protect nonobese diabetic mice from diabetes. J Exp Med (1994) 1.49
Autoimmune syndromes in major histocompatibility complex (MHC) congenic strains of nonobese diabetic (NOD) mice. The NOD MHC is dominant for insulitis and cyclophosphamide-induced diabetes. J Exp Med (1992) 1.46
Affected-sib-pair mapping of a novel susceptibility gene to insulin-dependent diabetes mellitus (IDDM8) on chromosome 6q25-q27. Am J Hum Genet (1995) 1.42
Local expression of transgene encoded TNF alpha in islets prevents autoimmune diabetes in nonobese diabetic (NOD) mice by preventing the development of auto-reactive islet-specific T cells. J Exp Med (1996) 1.39
Genetic analysis of the NZB contribution to lupus-like autoimmune disease in (NZB x NZW)F1 mice. Proc Natl Acad Sci U S A (1994) 1.35
Congenic mapping of the type 1 diabetes locus, Idd3, to a 780-kb region of mouse chromosome 3: identification of a candidate segment of ancestral DNA by haplotype mapping. Genome Res (2000) 1.34
Tissue- and age-specific changes in gene expression during disease induction and progression in NOD mice. Clin Immunol (2008) 1.33
I-E+ nonobese diabetic mice develop insulitis and diabetes. J Exp Med (1993) 1.32
Localization of two insulin-dependent diabetes (Idd) genes to the Idd10 region on mouse chromosome 3. Mamm Genome (1998) 1.27
Dual T cell receptor alpha chain T cells in autoimmunity. J Exp Med (1995) 1.26
Detection of genetic interference: simulation studies and mouse data. Genetics (1994) 1.23
Statistical evaluation of multiple-locus linkage data in experimental species and its relevance to human studies: application to nonobese diabetic (NOD) mouse and human insulin-dependent diabetes mellitus (IDDM). Am J Hum Genet (1993) 1.22
Locus controlling Bordetella pertussis-induced histamine sensitization (Bphs), an autoimmune disease-susceptibility gene, maps distal to T-cell receptor beta-chain gene on mouse chromosome 6. Proc Natl Acad Sci U S A (1993) 1.21
Mapping genes in the mouse using single-strand conformation polymorphism analysis of recombinant inbred strains and interspecific crosses. Proc Natl Acad Sci U S A (1992) 1.16
T-bet-deficient NOD mice are protected from diabetes due to defects in both T cell and innate immune system function. J Immunol (2009) 1.16
Mapping the mouse genome: current status and future prospects. Proc Natl Acad Sci U S A (1995) 1.08
pH-dependent peptide binding properties of the type I diabetes-associated I-Ag7 molecule: rapid release of CLIP at an endosomal pH. J Exp Med (1999) 1.08
Mapping quantitative trait loci in humans: achievements and limitations. J Clin Invest (2005) 1.08
Genetic mapping of tumor susceptibility genes involved in mouse plasmacytomagenesis. Proc Natl Acad Sci U S A (1993) 1.07
Identification of a new susceptibility locus for insulin-dependent diabetes mellitus by ancestral haplotype congenic mapping. J Clin Invest (1995) 1.06
Molecular aspects of type 1 diabetes. Mol Pathol (2003) 1.05
Multiple loci govern the bone marrow-derived immunoregulatory mechanism controlling dominant resistance to autoimmune orchitis. Proc Natl Acad Sci U S A (1995) 1.02
Fine mapping of the diabetes-susceptibility locus, IDDM4, on chromosome 11q13. Am J Hum Genet (1998) 1.01
Role of increased ROS dissipation in prevention of T1D. Ann N Y Acad Sci (2008) 1.01
Evidence of gene-gene interaction and age-at-diagnosis effects in type 1 diabetes. Diabetes (2012) 1.00
Apoptosis resistance of nonobese diabetic peripheral lymphocytes linked to the Idd5 diabetes susceptibility region. Proc Natl Acad Sci U S A (1997) 0.98
Synovial lymphocytes and the aetiology of synovitis. Ann Rheum Dis (1993) 0.97
Genetic and physiological association of diabetes susceptibility with raised Na+/H+ exchange activity. Proc Natl Acad Sci U S A (1994) 0.97
Nonobese diabetic congenic strain analysis of autoimmune diabetes reveals genetic complexity of the Idd18 locus and identifies Vav3 as a candidate gene. J Immunol (2010) 0.96
γδ T cells are essential effectors of type 1 diabetes in the nonobese diabetic mouse model. J Immunol (2013) 0.92
Evidence for the presence of insulin-dependent diabetes-associated alleles on the distal part of mouse chromosome 6. Genome Res (1998) 0.92
Genetic analysis of resistance to Type-1 Diabetes in ALR/Lt mice, a NOD-related strain with defenses against autoimmune-mediated diabetogenic stress. Immunogenetics (2003) 0.92
Two genetic loci regulate T cell-dependent islet inflammation and drive autoimmune diabetes pathogenesis. Am J Hum Genet (2000) 0.91
Genetics and neurobiology of aggression in Drosophila. Fly (Austin) (2012) 0.91
Genome-wide microarray expression analysis of CD4+ T Cells from nonobese diabetic congenic mice identifies Cd55 (Daf1) and Acadl as candidate genes for type 1 diabetes. J Immunol (2008) 0.91
Aod1, the immunoregulatory locus controlling abrogation of tolerance in neonatal thymectomy-induced autoimmune ovarian dysgenesis, maps to mouse chromosome 16. Proc Natl Acad Sci U S A (1995) 0.91
Genetic analysis of the LEW.1AR1-iddm rat: an animal model for spontaneous diabetes mellitus. Mamm Genome (2005) 0.91
Mouse chromosome 4. Mamm Genome (1992) 0.90
A non-MHC locus essential for autoimmune type I diabetes in the Komeda Diabetes-Prone rat. J Clin Invest (1997) 0.89
Regulatory T Cell Responses in Participants with Type 1 Diabetes after a Single Dose of Interleukin-2: A Non-Randomised, Open Label, Adaptive Dose-Finding Trial. PLoS Med (2016) 0.89
Genetic analysis of diabetes and insulitis in an interspecific cross of the nonobese diabetic mouse with Mus spretus. Proc Natl Acad Sci U S A (1993) 0.88
Collagen-induced arthritis in T cell receptor V beta congenic B10.Q mice. J Exp Med (1994) 0.86
Evidence for the genetic control of estradiol-regulated responses. Implications for variation in normal and pathological hormone-dependent phenotypes. Am J Pathol (1997) 0.86
The genetics of type I (insulin dependent) diabetes mellitus. J Med Genet (1992) 0.86
Commonalities of genetic resistance to spontaneous autoimmune and free radical--mediated diabetes. Free Radic Biol Med (2008) 0.85
Genetic control of anti-Sm autoantibody production in NOD congenic mice narrowed to the Idd9.3 region. Immunogenetics (2006) 0.85
Single-nucleotide polymorphisms in the IL2RA gene are associated with age at diagnosis in late-onset Finnish type 1 diabetes subjects. Immunogenetics (2009) 0.85
Analysis of HLA and disease susceptibility: chromosome 6 genes and sex influence long-QT phenotype. Am J Hum Genet (1994) 0.84
Mapping baroreceptor function to genome: a mathematical modeling approach. Genetics (2002) 0.84
Allelotyping of butadiene-induced lung and mammary adenocarcinomas of B6C3F1 mice: frequent losses of heterozygosity in regions homologous to human tumor-suppressor genes. Proc Natl Acad Sci U S A (1994) 0.84
Forward genetic approaches for elucidation of novel regulators of Lyme arthritis severity. Front Cell Infect Microbiol (2014) 0.84
Prevention of autoimmune insulitis in nonobese diabetic mice by expression of major histocompatibility complex class I Ld molecules. Proc Natl Acad Sci U S A (1992) 0.83
Mouse chromosome 4. Mamm Genome (1991) 0.83
Mouse chromosome 14. Mamm Genome (1992) 0.83
Isolation of monochromosomal hybrids for mouse chromosomes 3, 6, 10, 12, 14, and 18. Mamm Genome (1997) 0.82
A major histocompatibility complex class II restriction for BioBreeding/Worcester diabetes-inducing T cells. J Exp Med (1995) 0.82
Genetic control of diabetes mellitus. Diabetologia (1992) 0.82
T lymphomagenesis is determined by a dominant host gene thymic lymphoma susceptible mouse-1 (TLSM-1) in mouse models. J Exp Med (1994) 0.82
Mouse chromosome 9. Mamm Genome (1992) 0.82
Evidence for oligogenic inheritance of type 1 diabetes in a large Bedouin Arab family. J Clin Invest (1998) 0.81
The genetics of complex ophthalmic disorders. Br J Ophthalmol (1996) 0.81
Genetics of narcolepsy and other sleep disorders. Am J Hum Genet (1997) 0.81
Combining global genome and transcriptome approaches to identify the candidate genes of small-effect quantitative trait loci in collagen-induced arthritis. Arthritis Res Ther (2007) 0.81
Mouse chromosome 1. Mamm Genome (1992) 0.81
Dissecting genetic control of autoimmunity in NOD congenic mice. Immunol Res (2006) 0.81
Abnormal T cell selection on nod thymic epithelium is sufficient to induce autoimmune manifestations in C57BL/6 athymic nude mice. Proc Natl Acad Sci U S A (1997) 0.80
Genetic analysis of type 1 diabetes: embryonic stem cells as new tools to unlock biological mechanisms in type 1 diabetes. Rev Diabet Stud (2012) 0.78
Comparative genetics: synergizing human and NOD mouse studies for identifying genetic causation of type 1 diabetes. Rev Diabet Stud (2012) 0.78
Autoimmune orchitis, epididymitis, and vasitis are immunogenetically distinct lesions. Am J Pathol (1998) 0.77
The aggregation of the 5' insulin gene polymorphism in insulin dependent (type I) diabetes mellitus families. J Med Genet (1992) 0.77
Age and sex based genetic locus heterogeneity in type 1 diabetes. J Med Genet (2000) 0.76
Mouse chromosome 11. Mamm Genome (1992) 0.76
Mouse Models of Primary Sjogren's Syndrome. Curr Pharm Des (2015) 0.76
A gene(s) for all-trans-retinoic acid-induced forelimb defects mapped and confirmed to murine chromosome 11. Genetics (2005) 0.75
Grafts of supplementary thymuses injected with allogeneic pancreatic islets protect nonobese diabetic mice against diabetes. Proc Natl Acad Sci U S A (2002) 0.75
Does the locus on chromosome 11 implicated in susceptibility to HLA-DR4 dependent type I diabetes mellitus also affect susceptibility to rheumatoid arthritis? Ann Rheum Dis (1992) 0.75
Type 1 diabetes genes in rats: few or many? Diabetes (2009) 0.75
Genetics. Sweet mice, sugar daddies. Nature (1991) 0.75
Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-kappa B. Nature (1995) 10.36
MyD88 is an adaptor protein in the hToll/IL-1 receptor family signaling pathways. Mol Cell (1998) 8.73
Inhibition of NF-kappa B by sodium salicylate and aspirin. Science (1994) 7.60
Congenital leptin deficiency is associated with severe early-onset obesity in humans. Nature (1997) 7.33
Phosphorylation of NF-kappa B p65 by PKA stimulates transcriptional activity by promoting a novel bivalent interaction with the coactivator CBP/p300. Mol Cell (1998) 7.03
DNA binding and I kappa B inhibition of the cloned p65 subunit of NF-kappa B, a rel-related polypeptide. Cell (1991) 6.63
NF-kappaB and the immune response. Oncogene (2006) 5.62
The transcriptional activity of NF-kappaB is regulated by the IkappaB-associated PKAc subunit through a cyclic AMP-independent mechanism. Cell (1997) 4.99
NICE guidance on CardioQ(TM) oesophageal Doppler monitoring. Anaesthesia (2011) 4.63
Mapping of the inducible IkappaB phosphorylation sites that signal its ubiquitination and degradation. Mol Cell Biol (1996) 4.56
Signal transduction through NF-kappa B. Immunol Today (1998) 4.54
Selective inhibition of NF-kappaB activation by a peptide that blocks the interaction of NEMO with the IkappaB kinase complex. Science (2000) 4.04
Mapping genes for NIDDM. Design of the Finland-United States Investigation of NIDDM Genetics (FUSION) Study. Diabetes Care (1998) 3.99
I kappa B-beta regulates the persistent response in a biphasic activation of NF-kappa B. Cell (1995) 3.95
Rel-associated pp40: an inhibitor of the rel family of transcription factors. Science (1991) 3.76
The molecular mechanism of phase variation of H. influenzae lipopolysaccharide. Cell (1989) 3.60
Towards construction of a high resolution map of the mouse genome using PCR-analysed microsatellites. Nucleic Acids Res (1990) 3.59
Structure of NF-kappa B p50 homodimer bound to a kappa B site. Nature (1995) 3.59
Independent modes of transcriptional activation by the p50 and p65 subunits of NF-kappa B. Genes Dev (1992) 3.47
High-resolution manometry predicts the success of oesophageal bolus transport and identifies clinically important abnormalities not detected by conventional manometry. Neurogastroenterol Motil (2004) 3.44
Concern Randomised controlled trial of cardioprotective diet in patients with recent acute myocardial infarction: results of one year follow up. BMJ (1992) 3.14
Toll-like receptor-mediated NF-kappaB activation: a phylogenetically conserved paradigm in innate immunity. J Clin Invest (2001) 3.04
Linkage disequilibrium mapping of a type 1 diabetes susceptibility gene (IDDM7) to chromosome 2q31-q33. Nat Genet (1995) 2.93
Quantitative quality control in microarray image processing and data acquisition. Nucleic Acids Res (2001) 2.91
Type 1 diabetes in mice is linked to the interleukin-1 receptor and Lsh/Ity/Bcg genes on chromosome 1. Nature (1991) 2.84
Vaccination trials in rhesus monkeys with a minor, invariant, Plasmodium knowlesi 66 kD merozoite antigen. Parasite Immunol (1988) 2.79
Increased capsaicin receptor TRPV1-expressing sensory fibres in irritable bowel syndrome and their correlation with abdominal pain. Gut (2008) 2.77
Metabolic defects in lean nondiabetic offspring of NIDDM parents: a cross-sectional study. Diabetes (1997) 2.76
Review article: dermatological complications of immunosuppressive and anti-TNF therapy in inflammatory bowel disease. Aliment Pharmacol Ther (2013) 2.74
A highly conserved amino-acid sequence in thrombospondin, properdin and in proteins from sporozoites and blood stages of a human malaria parasite. Nature (1988) 2.70
Genes encoding ligands for deletion of V beta 11 T cells cosegregate with mammary tumour virus genomes. Nature (1991) 2.65
Insulin gene region-encoded susceptibility to type 1 diabetes is not restricted to HLA-DR4-positive individuals. Nat Genet (1992) 2.63
Utility of adiponectin as a biomarker predictive of glycemic efficacy is demonstrated by collaborative pooling of data from clinical trials conducted by multiple sponsors. Clin Pharmacol Ther (2009) 2.60
Direct demonstration of P-selectin- and VCAM-1-dependent mononuclear cell rolling in early atherosclerotic lesions of apolipoprotein E-deficient mice. Circ Res (1999) 2.60
Adiponectin--a key adipokine in the metabolic syndrome. Diabetes Obes Metab (2006) 2.58
NF-kappa B and rel proteins in innate immunity. Adv Immunol (1995) 2.53
Splenic T zone development is B cell dependent. J Exp Med (2001) 2.35
Mechanisms of mutations inhibiting fusion and infection by Semliki Forest virus. J Cell Biol (1996) 2.25
Intra-articular bupivacaine: potentially chondrotoxic? Br J Anaesth (2009) 2.20
The NF-kappa B p50 precursor, p105, contains an internal I kappa B-like inhibitor that preferentially inhibits p50. EMBO J (1992) 2.19
Cost-effectiveness of cognitive behaviour therapy for patients with chronic fatigue syndrome. QJM (2004) 2.18
ECSIT is an evolutionarily conserved intermediate in the Toll/IL-1 signal transduction pathway. Genes Dev (1999) 2.17
European evidence-based Consensus on the management of ulcerative colitis: Current management. J Crohns Colitis (2008) 2.14
Higher blood flow and circulating NO products offset high-altitude hypoxia among Tibetans. Proc Natl Acad Sci U S A (2007) 2.07
Parotid duct stenosis: interventional radiology to the rescue. Ann R Coll Surg Engl (1995) 2.05
Microsatellites for linkage analysis of genetic traits. Trends Genet (1992) 2.05
Substrate nucleotide-determined non-templated addition of adenine by Taq DNA polymerase: implications for PCR-based genotyping and cloning. Biotechniques (1996) 2.02
Inhaled nitric oxide in patients with normal and increased pulmonary vascular resistance after cardiac surgery. Br J Anaesth (1994) 2.01
A glycine-rich region in NF-kappaB p105 functions as a processing signal for the generation of the p50 subunit. Mol Cell Biol (1996) 2.01
Polygenic control of autoimmune diabetes in nonobese diabetic mice. Nat Genet (1993) 1.98
Infliximab in moderately severe glucocorticoid resistant ulcerative colitis: a randomised controlled trial. Gut (2003) 1.95
Activators of peroxisome proliferator-activated receptor gamma have depot-specific effects on human preadipocyte differentiation. J Clin Invest (1997) 1.95
A case for a combined mother and child card. Indian Pediatr (1987) 1.92
NF-kappa B activation by the pre-T cell receptor serves as a selective survival signal in T lymphocyte development. Immunity (2000) 1.91
Role of unphosphorylated, newly synthesized I kappa B beta in persistent activation of NF-kappa B. Mol Cell Biol (1996) 1.91
Two distinct Raf domains mediate interaction with Ras. J Biol Chem (1995) 1.88
Rel/NF-kappa B and I kappa B proteins: an overview. Semin Cancer Biol (1997) 1.88
Anaerobic acidogenesis of wastewater sludge. J Water Pollut Control Fed (1975) 1.87
A disease locus for hereditary haemorrhagic telangiectasia maps to chromosome 9q33-34. Nat Genet (1994) 1.81
Reactive oxygen species level in follicular fluid--embryo quality marker in IVF? Hum Reprod (2006) 1.80
Additional microsatellite markers for mouse genome mapping. Mamm Genome (1991) 1.79
Familiality of quantitative metabolic traits in Finnish families with non-insulin-dependent diabetes mellitus. Finland-United States Investigation of NIDDM Genetics (FUSION) Study investigators. Hum Hered (1999) 1.76
Resuturing following penetrating keratoplasty: a retrospective analysis. Br J Ophthalmol (2008) 1.75
An RGD-oligolysine peptide: a prototype construct for integrin-mediated gene delivery. Hum Gene Ther (1998) 1.73
Regulation of adipose cell number in man. Clin Sci (Lond) (1997) 1.72
Segmental bronchoprovocation in allergic rhinitis patients affects mast cell and basophil numbers in nasal and bronchial mucosa. Am J Respir Crit Care Med (2001) 1.72
Identifying physical activity patterns in chronic fatigue syndrome using actigraphic assessment. J Psychosom Res (2000) 1.72
Ligation of CD40 stimulates the induction of nitric-oxide synthase in microglial cells. J Biol Chem (2001) 1.71
Interleukin 6 secreted from adipose stromal cells promotes migration and invasion of breast cancer cells. Oncogene (2009) 1.69
A novel DNA recognition mode by the NF-kappa B p65 homodimer. Nat Struct Biol (1998) 1.68
Calmodulin activates intersubunit electron transfer in the neuronal nitric-oxide synthase dimer. J Biol Chem (2001) 1.68
Antigenic proteins of Mycobacterium leprae. Complete sequence of the gene for the 18-kDa protein. J Immunol (1988) 1.67
Cysticercosis causing single, small CT lesions in Indian patients with seizures. Lancet (1989) 1.66
Sirolimus in combination with tacrolimus and corticosteroids for the treatment of resistant chronic graft-versus-host disease. Br J Haematol (2005) 1.65
Socio-cultural factors affecting breast feeding and other infant feeding practices in an urban community. Indian Pediatr (1976) 1.64
Identification of susceptibility loci for insulin-dependent diabetes mellitus by trans-racial gene mapping. Nature (1989) 1.64
The generation of a library of PCR-analyzed microsatellite variants for genetic mapping of the mouse genome. Genomics (1991) 1.61
The use of malaria antibody tests in the prevention of transfusion-transmitted malaria. Vox Sang (2010) 1.60
Transcriptional activation of the cyclooxygenase-2 gene in endotoxin-treated RAW 264.7 macrophages. J Biol Chem (2000) 1.57
Airway inflammation is present during clinical remission of atopic asthma. Am J Respir Crit Care Med (2001) 1.57
Prevalence of diabetes and impaired fasting glucose in a selected population with special reference to influence of family history and anthropometric measurements--the Kolkata policeman study. J Assoc Physicians India (2008) 1.56
The solution structure of the Raf-1 cysteine-rich domain: a novel ras and phospholipid binding site. Proc Natl Acad Sci U S A (1996) 1.54
Leptin and the risk of Barrett's oesophagus. Gut (2008) 1.54
Phosphorylation of serine 51 in initiation factor 2 alpha (eIF2 alpha) promotes complex formation between eIF2 alpha(P) and eIF2B and causes inhibition in the guanine nucleotide exchange activity of eIF2B. Biochemistry (2000) 1.54